ATYR

aTyr Pharma

36 hedge funds and large institutions have $53.1M invested in aTyr Pharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

49% less capital invested

Capital invested by funds: $105M → $53.1M (-$51.9M)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

85% less call options, than puts

Call options by funds: $64K | Put options by funds: $436K

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$64K
Puts
$436K
Net Calls
Net Calls Change

Top Sellers

1 -$2.09M
2 -$855K
3 -$710K
4
IC
Ikarian Capital
Texas
-$197K
5
Two Sigma Investments
Two Sigma Investments
New York
-$160K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$14.8M
2
$11.9M
3
$3.96M
4
$3.82M
5
$3.23M
6
$3.15M
7
$2.75M
8
$1.7M
9
$1.26M
10
$1.06M
11
$823K
12
$765K
13
$675K
14
$521K
15
$505K
16
$450K
17
$427K
18
$418K
19
$235K
20
$132K
21
$130K
22
$107K
23
$62K
24
$57K
25
$36K